medigraphic.com
Asociación Mexicana de Gastroenterología

2005, Number 2

<< Back Next >>

Rev Gastroenterol Mex 2005; 70 (2)

Treatment results of enterocutaneous fistulae in patients with cancer

González-Ávila G, Quezada-Ramírez ME, Jiménez PE, Bello-Villalobos H

Language: Spanish
References: 24
Page: 158-163
PDF size: 44.54 Kb.


ABSTRACT

Background: Despite of advances obtained today, the enterocutaneous fistula has a mortality rate from 25 to 50%. The presence of cancer increases death frequency and makes difficult its treatment. Objective: Evaluate the results of management of enterocutaneous fistula in cancer patients. Methods: Seventy six cancer patients with average age of 56.8 ± 13.5 years old and received curative primary treatment for malignancy at the Oncology Hospital, National Medical Center in Mexico who developed an enterocutaneous fistula between 1992 and 2002 were studied. Results: Resolution of fistula was obtained in 52 patients (68.4%). Among these 52, 41 fistulae (53.9%) resolved spontaneously, and 11 required surgical treatment. All patients were treated with parenteral nutrition and octreotide. The meantime to fistula resolution, in those patients whose fistula was spontaneously resolved, was 20 days. Among the 24 patients who died, 21 had sepsis. Fistula-related mortality was highest in those patients with postoperative origin (82%; p = 0.024), of high output (57%; p = 0.001) and ileum site (45%; p = 0.04). Conclusions: The spontaneous closure is high and the surgical treatment is the best option. The mortality rate is moderate and sepsis the most frequent cause of death.


REFERENCES

  1. Fisher JE. The pathophysiology of enterocutaneous fistulas. World J Surg 1983; 7: 446.

  2. Schein M, Decker GAG. Postoperative external alimentary tract fistulas. Am J Surg 1991; 161: 435-8.

  3. Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative gastrointestinal fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69: 147-50.

  4. Kaur N, Minocha VR. Review of a hospital experience of enterocutaneous fistula. Trop Gastroenterol 2000; 21(4): 197-200.

  5. Spiliotis J, Briand D, Gouttebel MC, et al. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma. Surg Gynecol Obstet 1993; 176(6): 575-80.

  6. Alhan E, Calik A, Kucuktulu U. The management of enterocutaneous fistulas with parenteral hyperalimentation. Z Gastroenterol 1993; 31(11): 657-60.

  7. Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patient’s with gastrointestinal fistulas. World J Surg 1999; 23: 570-6.

  8. Meguid MM, Campos ACL. Preface: surgical management of gastrointestinal fistulas. Surg Clin North Am 1996; 76: XI.

  9. Sancho JJ, Di Costanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82: 638-41.

  10. Ayache S, Wadleigh RG. Treatment of a malignant enterocutaneous fistula with octreotide acetate. Cancer Invest 1999; 17(5): 320-1.

  11. Hernández-Aranda JC, Gallo-Chico B, Flores-Ramírez LA, y cols. Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition. Nutr Hosp 1996; 11(4): 226-9.

  12. Chang P, Chun JT, Bell JL. Complex enterocutaneous fistula: Closure with rectus abdominis muscle flap. South Med J 2000; 93(6): 599-602.

  13. Haffejjee AA. Surgical management of high output enterocutaneous fistula: a 24-year experience. Clin Nutr Metab Care 2004; 7(3): 309-16.

  14. Menmon AJ. Causes and management of postoperative enterocutaneous fistula. J Col Physicians Surg Park 2004; 14(1): 25-8.

  15. Li J. Management of enterocutaneous fistula: 30-year clinical experience. Chin Med J 2003; 116(2): 171-5.

  16. Arebi N, Forbes A. High-output fistula. Clin Colon Rectal Surg 2004; 17(2): 89-98.

  17. Kaushal M, Carlson GL. Management of enterocutaneous fistula. Clin Colon Rectal Surg 2004; 17(2): 79-88.

  18. Kearney R, Payne W, Rosemurgy A. Extra-abdominal closure of enterocutaneous fistula. Am Surg 1997; 6385: 406-9.

  19. McIntyre PB, Ritchie JK, Hawley PR, et al. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984; 71: 293.

  20. Oneschuk D, Bruera E. Successful management of multiple enterocutaneous fistulas in a patient with metastatic colon cancer. J Pain Symptom Manage 1997; 14(2): 121-4.

  21. Chamberlain RS, Kaufman HL, Danforth DN. Enterocutaneous fistula in cancer patients: etiology, management, outcome, and impact of further treatment. Am Surg 1998; 64(12): 1204-11.

  22. Roback SA, Nicoloff DM. High output enterocutaneous fistulas of the small bowel. Am J Surg 1972; 123: 317-22.

  23. Soeters PB, Ebeid Am, Fisher JE. Review of 404 patients with gastrointestinal fistula: Impact of parenteral nutrition. Ann Surg 1979; 190: 189-201.

  24. Doglietto GB, Bellantone R, Pacelli F. Enterocutaneous fistulas: Effect of nutritional management and surgery. Ital J Surg Sci 1989; 4: 375-80.




2020     |     www.medigraphic.com